AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇿🇦
Dalteparin Sodium in South Africa
6 products registered with SAHPRA — 0 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| FRAGMIN 2 500 IU / ml | X/8.2/89 | Pfizer Laboratories (Pty) Ltd | suspended | 31 Aug 2022 |
| FRAGMIN 2 500 IU | X/8.2/87 | Pfizer Laboratories (Pty) Ltd | suspended | 31 Aug 2022 |
| FRAGMIN 5 000 iu | X/8.2/88 | Pfizer Laboratories (Pty) Ltd | suspended | 31 Aug 2022 |
| FRAGMIN 12 500 IU/0,5 ml | 32/8.2/0472 | Pfizer Laboratories (Pty) Ltd | suspended | 31 Aug 2022 |
| FRAGMIN 15 000 IU/0,6 ml | 32/8.2/0473 | Pfizer Laboratories (Pty) Ltd | suspended | 31 Aug 2022 |
| FRAGMIN 18 000 IU/0,72 ml | 32/8.2/0474 | Pfizer Laboratories (Pty) Ltd | suspended | 31 Aug 2022 |
Dalteparin Sodium — SAHPRA Registration Details
SAHPRA (South Africa) has 6 registered products containing Dalteparin Sodium, of which 0 are currently active. Data is sourced directly from the official SAHPRA drug register and refreshed daily.
Track Dalteparin Sodium registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.